SCHEMBL9116347

SCHEMBL9116347

ClNc1ncnc2nc[nH]c12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 8/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ LMNA P02545 8/20 0.56
▸ CYP1A2 P05177 3/20 0.56
▸ PAK1 Q13153 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ HSD17B10 Q99714 3/20 0.54
▸ PKM P14618 1/20 0.54
▸ MKNK1 Q9BUB5 1/20 0.54
▸ TSHR P16473 3/20 0.53
▸ CDK2 P24941 2/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ PI4KA P42356 2/20 0.52
▸ PI4K2B Q8TCG2 2/20 0.52
▸ PI4K2A Q9BTU6 2/20 0.52
▸ PI4KB Q9UBF8 2/20 0.52
▸ DRD3 P35462 1/20 0.52
▸ XDH P47989 1/20 0.52
▸ LRRK2 Q5S007 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11591794 0.82 HTT (0.59) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL30374699 0.80 MKNK1 (0.58) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL29380490 0.80 HTT (0.62) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL1095418 0.80 CYP1A2 (0.60) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL21914 0.80 HTT (0.62) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL160074 0.80 CYP3A4 (0.62) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL29420373 0.80 CYP3A4 (0.62) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL17901710 0.80 HTT (0.57) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL10918760 0.78 HTT (0.60) HTTCYP3A4LMNACYP1A2PAK1
SCHEMBL6243538 0.78 HTT (0.60) HTTCYP3A4LMNACYP1A2PAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5478928-A Useful as antiviral agents in the treatment and prevention of AIDS SOUTHERN RESEARCH INSTITUTE (US) 1995-12-26 — — US claimed
WO-1995011685-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1995-05-04 — — WO claimed
US-5478928-A Useful as antiviral agents in the treatment and prevention of AIDS SOUTHERN RESEARCH INSTITUTE (US) 1995-12-26 — — US disclosed
WO-1995011685-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1995-05-04 — — WO disclosed
EP-0525106-A4 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS — 1993-04-21 — — EP disclosed
EP-0525106-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1993-02-03 — — EP disclosed
US-5128458-A 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 1992-07-07 — — US disclosed
WO-1991016333-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1991-10-31 — — WO disclosed
Send feedback